Table 1.
Age (Years) | Number | Percentage |
---|---|---|
<40 | 26 | 55% |
41–60 | 17 | 36% |
>60 | 4 | 9% |
Bilateral BC | ||
Yes | 9 | 19% |
No | 38 | 81% |
TNBC | ||
Yes | 26 | 55% |
No | 18 | 38% |
Unknown | 3 | 7% |
Tumor hormone receptor status | ||
ER | ||
Positive | 19 | 40% |
Negative | 27 | 57% |
Unknown | 1 | 3% |
PR | ||
Positive | 16 | 34% |
Negative | 28 | 59% |
Unknown | 3 | 6% |
HER2 status | ||
Positive | 6 | 12% |
Negative | 36 | 76% |
Unknown | 5 | 12% |
Stage at diagnosis | ||
I | 3 | 6% |
II | 24 | 51% |
III | 11 | 23% |
Unknown | 9 | 19% |
Grade | ||
2 | 11 | 23% |
3 | 30 | 64% |
Unknown | 6 | 13% |
Total | 47 patients 100% |